Synthesis and in vitro antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma via apoptosis-related mechanisms
RSC Advances · 2026 · 16 (38) · 42765-42777
DOI: 10.1039/d6ra04127b ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Xixi Hou und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology Luoyang 471003 China Docyix1969@126.com. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Dolutegravir derivatives bearing 1,2,3-triazole moieties 3b and 3i exhibited potent antiproliferative activity against HepG2 cells.
Autor:innen und Institutionen
- The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology Luoyang 471003 China Docyix1969@126.com.
- College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology 263 Kaiyuan Road Luoyang 471003 China yaoqiyan66@126.com.
ORCID-Profile: Qingqing Zhang, Qiyan Yao
Zitieren
APA
Hou, X., Huang, M., Zhang, Q., Yao, Q., & Yang, J. (2026). Synthesis and in vitro antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma via apoptosis-related mechanisms. RSC Advances, 16(38), 42765-42777. https://doi.org/10.1039/d6ra04127b
Vancouver
Hou X, Huang M, Zhang Q, Yao Q, Yang J. Synthesis and in vitro antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma via apoptosis-related mechanisms. RSC Advances. 2026;16(38):42765-42777. doi:10.1039/d6ra04127b
BibTeX
@article{Hou2026,
author = {Hou, Xixi and Huang, Mengmeng and Zhang, Qingqing and Yao, Qiyan and Yang, Jianxue},
title = {Synthesis and in vitro antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma via apoptosis-related mechanisms},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {38},
pages = {42765--42777},
doi = {10.1039/d6ra04127b}
}
EUVIMED